申请人:Jinno Madoka
公开号:US20090291977A1
公开(公告)日:2009-11-26
This invention relates to compounds of the formula (I): or a pharmaceutically acceptable salt thereof, wherein: R′, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, R
8
A and B are each as described herein or a pharmaceutically acceptable salt, and compositions containing such compounds and the method of treatment and the use, comprising such compounds for the treatment of a condition mediated by acid pump antagonistic activity such as, but not limited to, as gastrointestinal disease, gastroesophageal disease, gastroesophageal reflux disease (GERD), peptic ulcer, gastric ulcer, duodenal ulcer, NSAID-induced ulcers, gastritis, infection of
Helicobacter pylori
, dyspepsia, functional dyspepsia, Zollinger-Ellison syndrome, non-crosive reflux disease (NERD), visceral pain, heartburn, nausea, esophagitis, dysphagia, hypersalivation, airway disorders or asthma.
本发明涉及式(I)的化合物或其药学上可接受的盐,其中:R′、R2、R3、R4、R5、R6、R7、R8A和B分别如本文所述或其药学上可接受的盐,以及含有这种化合物的组合物、治疗方法和使用,包括用于治疗酸泵拮抗活性介导的疾病,如但不限于胃肠疾病、胃食管疾病、胃食管反流病(GERD)、消化性溃疡、胃溃疡、十二指肠溃疡、NSAID所致溃疡、胃炎、幽门螺杆菌感染、消化不良、功能性消化不良、佐林格-埃里森综合征、非腐蚀性反流病(NERD)、内脏疼痛、心口灼热、恶心、食管炎、吞咽困难、多唾液、呼吸道疾病或哮喘。